Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis

Background: The purpose of this meta-analysis was to evaluate the controversy of angiotensin-converting enzyme inhibitor (ACEI) in combination with angiotensin-receptor blocker (ARB) in the treatment of chronic kidney disease (CKD) based on dose. Methods: PubMed, EMBASE, and Cochrane Library were se...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mingming, Wang, Rumeng, Yu, Yi, Chang, Meiying, Ma, Sijia, Zhang, Hanwen, Qu, Hua, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134749/
https://www.ncbi.nlm.nih.gov/pubmed/34025408
http://dx.doi.org/10.3389/fphar.2021.638611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134749/
https://www.ncbi.nlm.nih.gov/pubmed/34025408
http://dx.doi.org/10.3389/fphar.2021.638611

Ejemplares similares